NZ256178A - Use of diureidobenzenedisulphonate oligomers in medicaments - Google Patents

Use of diureidobenzenedisulphonate oligomers in medicaments

Info

Publication number
NZ256178A
NZ256178A NZ256178A NZ25617893A NZ256178A NZ 256178 A NZ256178 A NZ 256178A NZ 256178 A NZ256178 A NZ 256178A NZ 25617893 A NZ25617893 A NZ 25617893A NZ 256178 A NZ256178 A NZ 256178A
Authority
NZ
New Zealand
Prior art keywords
compound
binding
inositol
oligomers
calcium
Prior art date
Application number
NZ256178A
Other languages
English (en)
Inventor
Kenneth Alan Stauderman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NZ256178A publication Critical patent/NZ256178A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ256178A 1992-09-28 1993-08-30 Use of diureidobenzenedisulphonate oligomers in medicaments NZ256178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
NZ256178A true NZ256178A (en) 1997-03-24

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ256178A NZ256178A (en) 1992-09-28 1993-08-30 Use of diureidobenzenedisulphonate oligomers in medicaments

Country Status (13)

Country Link
EP (1) EP0661982A1 (en, 2012)
JP (1) JPH08502068A (en, 2012)
KR (1) KR950703347A (en, 2012)
AU (1) AU670962B2 (en, 2012)
CA (1) CA2145681A1 (en, 2012)
HU (1) HUT70192A (en, 2012)
IL (1) IL107066A (en, 2012)
MX (1) MX9305933A (en, 2012)
NO (1) NO951163L (en, 2012)
NZ (1) NZ256178A (en, 2012)
TW (1) TW260663B (en, 2012)
WO (1) WO1994007507A1 (en, 2012)
ZA (1) ZA936978B (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000586A2 (en) * 1994-06-30 1996-01-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for treating cell proliferative disorders by modulating signal transduction
JPH11503110A (ja) 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
KR20000022274A (ko) * 1996-06-27 2000-04-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Il-8 수용체 길항제
IL127667A0 (en) 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
WO2002038140A2 (en) * 2000-11-09 2002-05-16 Contrimmune Biotechnology Inc Therapeutic uses for ip3 receptor-mediated calcium channel modulators
MX2014002535A (es) 2011-09-02 2015-07-17 Univ Columbia Inhibidores de camkii, ip3r, calcineurina, p38 y mk2/3 para tratar las alteraciones metabolicas de la obesidad.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
ZA936978B (en) 1994-04-18
HU9500891D0 (en) 1995-05-29
WO1994007507A1 (en) 1994-04-14
IL107066A (en) 1998-01-04
TW260663B (en, 2012) 1995-10-21
AU4841793A (en) 1994-04-26
IL107066A0 (en) 1993-12-28
KR950703347A (ko) 1995-09-20
HUT70192A (en) 1995-09-28
NO951163D0 (no) 1995-03-27
AU670962B2 (en) 1996-08-08
JPH08502068A (ja) 1996-03-05
CA2145681A1 (en) 1994-04-14
NO951163L (no) 1995-03-27
MX9305933A (es) 1994-04-29
EP0661982A1 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
US5786344A (en) Camptothecin drug combinations and methods with reduced side effects
McNeal et al. [3H] Batrachotoxinin A 20. alpha.-benzoate binding to voltage-sensitive sodium channels: a rapid and quanitative assay for local anesthetic activity in a variety of drugs
Silveira et al. Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases
US5204329A (en) Treatment of organ transplantation rejection
NZ256178A (en) Use of diureidobenzenedisulphonate oligomers in medicaments
US7501436B2 (en) 5-HT3 receptor antagonists and methods of use
JPH05507291A (ja) 医薬組成物およびその製法
CN105934433B (zh) A3腺苷受体激动剂
ZA200105835B (en) Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands.
Allison et al. Inhibition of the effect of lithium on brain inositol by atropine and scopolamine
US20050043327A1 (en) Pharmaceutical composition for the prevention and treatment of addiction in a mammal
TW201922246A (zh) 以ccr2拮抗劑治療局部性腎絲球硬化症
Mohr et al. Structure/activity relationships of M 2 muscarinic allosteric modulators
US5939426A (en) Methods for treating urinary incontinence using descarboethoxyloratadine
KR20030088445A (ko) Ｎ-부-3-테닐 노르부프레노르핀 및 사용방법
EP0960111B1 (en) Morphine derivatives with analgesic activity
Alhaider et al. The quipazine-and YFMPP-increased conditioned avoidance response in rats: role of 5-HT1C/5-HT2 receptors
US20030008848A1 (en) Small molecules useful in the treatment of inflammatory disease
Onali et al. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex
Liebmann et al. Pharmacological and molecular actions of the bradykinin B2 receptor antagonist, Hoe 140, in the rat uterus
Whitehouse Benzodiazepines and steroidogenesis
Birdsall et al. The effect of p-chloromercuribenzoate on structure-binding relationships of muscarinic receptors in the rat cerebral cortex
IE57468B1 (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
KR20060009314A (ko) 포유동물에서 니코틴 탐닉증을 예방 및 치료하기 위한약제학적 조성물
US20040224962A1 (en) Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss